Global Kidney Medicine Market Growth 2025-2031

December 2025 | 108 pages | ID: GDA5823A30D2EN
LP Information

Abstracts

The global Kidney Medicine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Kidney medicine is used for deficiency of kidney essence, impotence and smoothness caused by insufficient yuan Yang, cold waist and knee, short breath and fatigue

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Kidney Medicine Industry Forecast” looks at past sales and reviews total world Kidney Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Kidney Medicine sales for 2025 through 2031. With Kidney Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Kidney Medicine industry.

This Insight Report provides a comprehensive analysis of the global Kidney Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Kidney Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Kidney Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Kidney Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Kidney Medicine.

This report presents a comprehensive overview, market shares, and growth opportunities of Kidney Medicine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Tablet
• Capsule
• Oral Liquid

Segmentation by Application:

• Hospital
• Pharmacy
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Roche
• Sanofi
• Novartis
• Amgen
• Xiuzheng Pharmaceutical Group
• Xiaolin Zhiyao
• Henan Lingrui Pharmaceutical
• Kuihua yaoye
• Sanjiu Pharmaceutical
• Harbin Pharmaceutical Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Kidney Medicine market?

What factors are driving Kidney Medicine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Kidney Medicine market opportunities vary by end market size?

How does Kidney Medicine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Kidney Medicine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Kidney Medicine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Kidney Medicine by Country/Region, 2020, 2024 & 2031
2.2 Kidney Medicine Segment by Type
  2.2.1 Tablet
  2.2.2 Capsule
  2.2.3 Oral Liquid
2.3 Kidney Medicine Sales by Type
  2.3.1 Global Kidney Medicine Sales Market Share by Type (2020-2025)
  2.3.2 Global Kidney Medicine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Kidney Medicine Sale Price by Type (2020-2025)
2.4 Kidney Medicine Segment by Application
  2.4.1 Hospital
  2.4.2 Pharmacy
  2.4.3 Others
2.5 Kidney Medicine Sales by Application
  2.5.1 Global Kidney Medicine Sale Market Share by Application (2020-2025)
  2.5.2 Global Kidney Medicine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Kidney Medicine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Kidney Medicine Breakdown Data by Company
  3.1.1 Global Kidney Medicine Annual Sales by Company (2020-2025)
  3.1.2 Global Kidney Medicine Sales Market Share by Company (2020-2025)
3.2 Global Kidney Medicine Annual Revenue by Company (2020-2025)
  3.2.1 Global Kidney Medicine Revenue by Company (2020-2025)
  3.2.2 Global Kidney Medicine Revenue Market Share by Company (2020-2025)
3.3 Global Kidney Medicine Sale Price by Company
3.4 Key Manufacturers Kidney Medicine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Kidney Medicine Product Location Distribution
  3.4.2 Players Kidney Medicine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR KIDNEY MEDICINE BY GEOGRAPHIC REGION

4.1 World Historic Kidney Medicine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Kidney Medicine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Kidney Medicine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Kidney Medicine Market Size by Country/Region (2020-2025)
  4.2.1 Global Kidney Medicine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Kidney Medicine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Kidney Medicine Sales Growth
4.4 APAC Kidney Medicine Sales Growth
4.5 Europe Kidney Medicine Sales Growth
4.6 Middle East & Africa Kidney Medicine Sales Growth

5 AMERICAS

5.1 Americas Kidney Medicine Sales by Country
  5.1.1 Americas Kidney Medicine Sales by Country (2020-2025)
  5.1.2 Americas Kidney Medicine Revenue by Country (2020-2025)
5.2 Americas Kidney Medicine Sales by Type (2020-2025)
5.3 Americas Kidney Medicine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Kidney Medicine Sales by Region
  6.1.1 APAC Kidney Medicine Sales by Region (2020-2025)
  6.1.2 APAC Kidney Medicine Revenue by Region (2020-2025)
6.2 APAC Kidney Medicine Sales by Type (2020-2025)
6.3 APAC Kidney Medicine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Kidney Medicine by Country
  7.1.1 Europe Kidney Medicine Sales by Country (2020-2025)
  7.1.2 Europe Kidney Medicine Revenue by Country (2020-2025)
7.2 Europe Kidney Medicine Sales by Type (2020-2025)
7.3 Europe Kidney Medicine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Kidney Medicine by Country
  8.1.1 Middle East & Africa Kidney Medicine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Kidney Medicine Revenue by Country (2020-2025)
8.2 Middle East & Africa Kidney Medicine Sales by Type (2020-2025)
8.3 Middle East & Africa Kidney Medicine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Kidney Medicine
10.3 Manufacturing Process Analysis of Kidney Medicine
10.4 Industry Chain Structure of Kidney Medicine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Kidney Medicine Distributors
11.3 Kidney Medicine Customer

12 WORLD FORECAST REVIEW FOR KIDNEY MEDICINE BY GEOGRAPHIC REGION

12.1 Global Kidney Medicine Market Size Forecast by Region
  12.1.1 Global Kidney Medicine Forecast by Region (2026-2031)
  12.1.2 Global Kidney Medicine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Kidney Medicine Forecast by Type (2026-2031)
12.7 Global Kidney Medicine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Kidney Medicine Product Portfolios and Specifications
  13.1.3 Pfizer Kidney Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 Roche
  13.2.1 Roche Company Information
  13.2.2 Roche Kidney Medicine Product Portfolios and Specifications
  13.2.3 Roche Kidney Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Roche Main Business Overview
  13.2.5 Roche Latest Developments
13.3 Sanofi
  13.3.1 Sanofi Company Information
  13.3.2 Sanofi Kidney Medicine Product Portfolios and Specifications
  13.3.3 Sanofi Kidney Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Sanofi Main Business Overview
  13.3.5 Sanofi Latest Developments
13.4 Novartis
  13.4.1 Novartis Company Information
  13.4.2 Novartis Kidney Medicine Product Portfolios and Specifications
  13.4.3 Novartis Kidney Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Novartis Main Business Overview
  13.4.5 Novartis Latest Developments
13.5 Amgen
  13.5.1 Amgen Company Information
  13.5.2 Amgen Kidney Medicine Product Portfolios and Specifications
  13.5.3 Amgen Kidney Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Amgen Main Business Overview
  13.5.5 Amgen Latest Developments
13.6 Xiuzheng Pharmaceutical Group
  13.6.1 Xiuzheng Pharmaceutical Group Company Information
  13.6.2 Xiuzheng Pharmaceutical Group Kidney Medicine Product Portfolios and Specifications
  13.6.3 Xiuzheng Pharmaceutical Group Kidney Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Xiuzheng Pharmaceutical Group Main Business Overview
  13.6.5 Xiuzheng Pharmaceutical Group Latest Developments
13.7 Xiaolin Zhiyao
  13.7.1 Xiaolin Zhiyao Company Information
  13.7.2 Xiaolin Zhiyao Kidney Medicine Product Portfolios and Specifications
  13.7.3 Xiaolin Zhiyao Kidney Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Xiaolin Zhiyao Main Business Overview
  13.7.5 Xiaolin Zhiyao Latest Developments
13.8 Henan Lingrui Pharmaceutical
  13.8.1 Henan Lingrui Pharmaceutical Company Information
  13.8.2 Henan Lingrui Pharmaceutical Kidney Medicine Product Portfolios and Specifications
  13.8.3 Henan Lingrui Pharmaceutical Kidney Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Henan Lingrui Pharmaceutical Main Business Overview
  13.8.5 Henan Lingrui Pharmaceutical Latest Developments
13.9 Kuihua yaoye
  13.9.1 Kuihua yaoye Company Information
  13.9.2 Kuihua yaoye Kidney Medicine Product Portfolios and Specifications
  13.9.3 Kuihua yaoye Kidney Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Kuihua yaoye Main Business Overview
  13.9.5 Kuihua yaoye Latest Developments
13.10 Sanjiu Pharmaceutical
  13.10.1 Sanjiu Pharmaceutical Company Information
  13.10.2 Sanjiu Pharmaceutical Kidney Medicine Product Portfolios and Specifications
  13.10.3 Sanjiu Pharmaceutical Kidney Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Sanjiu Pharmaceutical Main Business Overview
  13.10.5 Sanjiu Pharmaceutical Latest Developments
13.11 Harbin Pharmaceutical Group
  13.11.1 Harbin Pharmaceutical Group Company Information
  13.11.2 Harbin Pharmaceutical Group Kidney Medicine Product Portfolios and Specifications
  13.11.3 Harbin Pharmaceutical Group Kidney Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Harbin Pharmaceutical Group Main Business Overview
  13.11.5 Harbin Pharmaceutical Group Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Kidney Medicine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Kidney Medicine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablet
Table 4. Major Players of Capsule
Table 5. Major Players of Oral Liquid
Table 6. Global Kidney Medicine Sales by Type (2020-2025) & (K Units)
Table 7. Global Kidney Medicine Sales Market Share by Type (2020-2025)
Table 8. Global Kidney Medicine Revenue by Type (2020-2025) & ($ million)
Table 9. Global Kidney Medicine Revenue Market Share by Type (2020-2025)
Table 10. Global Kidney Medicine Sale Price by Type (2020-2025) & (US$/Unit)
Table 11. Global Kidney Medicine Sale by Application (2020-2025) & (K Units)
Table 12. Global Kidney Medicine Sale Market Share by Application (2020-2025)
Table 13. Global Kidney Medicine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Kidney Medicine Revenue Market Share by Application (2020-2025)
Table 15. Global Kidney Medicine Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Kidney Medicine Sales by Company (2020-2025) & (K Units)
Table 17. Global Kidney Medicine Sales Market Share by Company (2020-2025)
Table 18. Global Kidney Medicine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Kidney Medicine Revenue Market Share by Company (2020-2025)
Table 20. Global Kidney Medicine Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Kidney Medicine Producing Area Distribution and Sales Area
Table 22. Players Kidney Medicine Products Offered
Table 23. Kidney Medicine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Kidney Medicine Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Kidney Medicine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Kidney Medicine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Kidney Medicine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Kidney Medicine Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Kidney Medicine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Kidney Medicine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Kidney Medicine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Kidney Medicine Sales by Country (2020-2025) & (K Units)
Table 35. Americas Kidney Medicine Sales Market Share by Country (2020-2025)
Table 36. Americas Kidney Medicine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Kidney Medicine Sales by Type (2020-2025) & (K Units)
Table 38. Americas Kidney Medicine Sales by Application (2020-2025) & (K Units)
Table 39. APAC Kidney Medicine Sales by Region (2020-2025) & (K Units)
Table 40. APAC Kidney Medicine Sales Market Share by Region (2020-2025)
Table 41. APAC Kidney Medicine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Kidney Medicine Sales by Type (2020-2025) & (K Units)
Table 43. APAC Kidney Medicine Sales by Application (2020-2025) & (K Units)
Table 44. Europe Kidney Medicine Sales by Country (2020-2025) & (K Units)
Table 45. Europe Kidney Medicine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Kidney Medicine Sales by Type (2020-2025) & (K Units)
Table 47. Europe Kidney Medicine Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Kidney Medicine Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Kidney Medicine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Kidney Medicine Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Kidney Medicine Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Kidney Medicine
Table 53. Key Market Challenges & Risks of Kidney Medicine
Table 54. Key Industry Trends of Kidney Medicine
Table 55. Kidney Medicine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Kidney Medicine Distributors List
Table 58. Kidney Medicine Customer List
Table 59. Global Kidney Medicine Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Kidney Medicine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Kidney Medicine Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Kidney Medicine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Kidney Medicine Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Kidney Medicine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Kidney Medicine Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Kidney Medicine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Kidney Medicine Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Kidney Medicine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Kidney Medicine Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Kidney Medicine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Kidney Medicine Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Kidney Medicine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Pfizer Basic Information, Kidney Medicine Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Kidney Medicine Product Portfolios and Specifications
Table 75. Pfizer Kidney Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Roche Basic Information, Kidney Medicine Manufacturing Base, Sales Area and Its Competitors
Table 79. Roche Kidney Medicine Product Portfolios and Specifications
Table 80. Roche Kidney Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Sanofi Basic Information, Kidney Medicine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Kidney Medicine Product Portfolios and Specifications
Table 85. Sanofi Kidney Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Novartis Basic Information, Kidney Medicine Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Kidney Medicine Product Portfolios and Specifications
Table 90. Novartis Kidney Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Amgen Basic Information, Kidney Medicine Manufacturing Base, Sales Area and Its Competitors
Table 94. Amgen Kidney Medicine Product Portfolios and Specifications
Table 95. Amgen Kidney Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Amgen Main Business
Table 97. Amgen Latest Developments
Table 98. Xiuzheng Pharmaceutical Group Basic Information, Kidney Medicine Manufacturing Base, Sales Area and Its Competitors
Table 99. Xiuzheng Pharmaceutical Group Kidney Medicine Product Portfolios and Specifications
Table 100. Xiuzheng Pharmaceutical Group Kidney Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Xiuzheng Pharmaceutical Group Main Business
Table 102. Xiuzheng Pharmaceutical Group Latest Developments
Table 103. Xiaolin Zhiyao Basic Information, Kidney Medicine Manufacturing Base, Sales Area and Its Competitors
Table 104. Xiaolin Zhiyao Kidney Medicine Product Portfolios and Specifications
Table 105. Xiaolin Zhiyao Kidney Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Xiaolin Zhiyao Main Business
Table 107. Xiaolin Zhiyao Latest Developments
Table 108. Henan Lingrui Pharmaceutical Basic Information, Kidney Medicine Manufacturing Base, Sales Area and Its Competitors
Table 109. Henan Lingrui Pharmaceutical Kidney Medicine Product Portfolios and Specifications
Table 110. Henan Lingrui Pharmaceutical Kidney Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Henan Lingrui Pharmaceutical Main Business
Table 112. Henan Lingrui Pharmaceutical Latest Developments
Table 113. Kuihua yaoye Basic Information, Kidney Medicine Manufacturing Base, Sales Area and Its Competitors
Table 114. Kuihua yaoye Kidney Medicine Product Portfolios and Specifications
Table 115. Kuihua yaoye Kidney Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Kuihua yaoye Main Business
Table 117. Kuihua yaoye Latest Developments
Table 118. Sanjiu Pharmaceutical Basic Information, Kidney Medicine Manufacturing Base, Sales Area and Its Competitors
Table 119. Sanjiu Pharmaceutical Kidney Medicine Product Portfolios and Specifications
Table 120. Sanjiu Pharmaceutical Kidney Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Sanjiu Pharmaceutical Main Business
Table 122. Sanjiu Pharmaceutical Latest Developments
Table 123. Harbin Pharmaceutical Group Basic Information, Kidney Medicine Manufacturing Base, Sales Area and Its Competitors
Table 124. Harbin Pharmaceutical Group Kidney Medicine Product Portfolios and Specifications
Table 125. Harbin Pharmaceutical Group Kidney Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Harbin Pharmaceutical Group Main Business
Table 127. Harbin Pharmaceutical Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Kidney Medicine
Figure 2. Kidney Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Kidney Medicine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Kidney Medicine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Kidney Medicine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Kidney Medicine Sales Market Share by Country/Region (2024)
Figure 10. Kidney Medicine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTablet
Figure 12. Product Picture of Capsule
Figure 13. Product Picture of Oral Liquid
Figure 14. Global Kidney Medicine Sales Market Share by Type in 2025
Figure 15. Global Kidney Medicine Revenue Market Share by Type (2020-2025)
Figure 16. Kidney Medicine Consumed in Hospital
Figure 17. Global Kidney Medicine Market: Hospital (2020-2025) & (K Units)
Figure 18. Kidney Medicine Consumed in Pharmacy
Figure 19. Global Kidney Medicine Market: Pharmacy (2020-2025) & (K Units)
Figure 20. Kidney Medicine Consumed in Others
Figure 21. Global Kidney Medicine Market: Others (2020-2025) & (K Units)
Figure 22. Global Kidney Medicine Sale Market Share by Application (2024)
Figure 23. Global Kidney Medicine Revenue Market Share by Application in 2025
Figure 24. Kidney Medicine Sales by Company in 2025 (K Units)
Figure 25. Global Kidney Medicine Sales Market Share by Company in 2025
Figure 26. Kidney Medicine Revenue by Company in 2025 ($ millions)
Figure 27. Global Kidney Medicine Revenue Market Share by Company in 2025
Figure 28. Global Kidney Medicine Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Kidney Medicine Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Kidney Medicine Sales 2020-2025 (K Units)
Figure 31. Americas Kidney Medicine Revenue 2020-2025 ($ millions)
Figure 32. APAC Kidney Medicine Sales 2020-2025 (K Units)
Figure 33. APAC Kidney Medicine Revenue 2020-2025 ($ millions)
Figure 34. Europe Kidney Medicine Sales 2020-2025 (K Units)
Figure 35. Europe Kidney Medicine Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Kidney Medicine Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Kidney Medicine Revenue 2020-2025 ($ millions)
Figure 38. Americas Kidney Medicine Sales Market Share by Country in 2025
Figure 39. Americas Kidney Medicine Revenue Market Share by Country (2020-2025)
Figure 40. Americas Kidney Medicine Sales Market Share by Type (2020-2025)
Figure 41. Americas Kidney Medicine Sales Market Share by Application (2020-2025)
Figure 42. United States Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Kidney Medicine Sales Market Share by Region in 2025
Figure 47. APAC Kidney Medicine Revenue Market Share by Region (2020-2025)
Figure 48. APAC Kidney Medicine Sales Market Share by Type (2020-2025)
Figure 49. APAC Kidney Medicine Sales Market Share by Application (2020-2025)
Figure 50. China Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 54. India Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Kidney Medicine Sales Market Share by Country in 2025
Figure 58. Europe Kidney Medicine Revenue Market Share by Country (2020-2025)
Figure 59. Europe Kidney Medicine Sales Market Share by Type (2020-2025)
Figure 60. Europe Kidney Medicine Sales Market Share by Application (2020-2025)
Figure 61. Germany Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 62. France Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Kidney Medicine Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Kidney Medicine Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Kidney Medicine Sales Market Share by Application (2020-2025)
Figure 69. Egypt Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Kidney Medicine Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Kidney Medicine in 2025
Figure 75. Manufacturing Process Analysis of Kidney Medicine
Figure 76. Industry Chain Structure of Kidney Medicine
Figure 77. Channels of Distribution
Figure 78. Global Kidney Medicine Sales Market Forecast by Region (2026-2031)
Figure 79. Global Kidney Medicine Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Kidney Medicine Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Kidney Medicine Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Kidney Medicine Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Kidney Medicine Revenue Market Share Forecast by Application (2026-2031)